In-silico prioritization of fragment hits from observed protein-ligand interactions

In the rapidly evolving field of drug discovery and cheminformatics, fragment-based drug discovery (FBDD) has become a key strategy, and one that is increasingly accessible, thanks to facilities like XChem at Diamond Light Source, which provides primary screening by protein crystallography to tens of academic and industrial projects annually.…